• Blog
  • Single Use Systems Market Report

    Single Use Systems Market Report

    Single Use Systems Market Report
    Report code - SR2782 Published On : Jan,2024 No. of Pages: 150
    Single-Use Systems Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth O See more...

    Market Highlights

    Single-use systems for bioprocess solutions refer to the use of disposable, or single-use, components in the manufacturing and processing of biopharmaceuticals. Single-use technologies offer several advantages in terms of flexibility, cost-effectiveness, and reduced risk of cross-contamination. These solutions allow for more flexible and scalable manufacturing processes. As a result, biopharmaceutical companies can easily adjust their production capacities based on demand without the need for extensive facility modifications.

    In recent years, the biopharmaceutical industry has witnessed significant growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in biotechnology, and a growing aging population. Continuous advancements in bioprocessing technologies, including single-use systems, have played a crucial role in enhancing efficiency, reducing costs, and improving flexibility in biopharmaceutical manufacturing. Single-use bioprocessing systems have gained popularity due to their advantages, such as reduced contamination risk, faster turnaround times, and lower capital expenditures compared to traditional stainless-steel systems. These technologies also offer greater flexibility and scalability, allowing biopharmaceutical companies to adapt quickly to the changing market demands and scale production as needed.

    In addition, the World Health Organization (WHO) has been increasingly supportive of single-use technologies, provided that they meet the required quality and safety standards. This has encouraged more companies to adopt single-use systems in their biopharmaceutical processes. Overall, the single-use systems market is likely to grow at an exceptional CAGR of 16.3% in the long run to reach US$ 17 billion in 2030.

    Recent Developments:

    • In April 2023, Merck KGaA announced the launch of its Ultimus single-use process container film, designed to provide extreme durability and leak resistance for single-use assemblies used for bioprocessing liquid applications.
    • In March 2020, Thermo Fisher Scientific Inc. invested over US$ 475 million to enhance biologics development, manufacturing, and cell and gene therapy capabilities at its St. Louis site in Missouri. In addition, the site completed its expansion, doubling its single-use production capacity for biological drug substance development and commercial manufacturing.

     Merger & Acquisitions: In recent years, there have been a fair number of strategic alliances, including M&As, JVs, etc., in the biopharmaceutical industry across the globe. Some of them have been mentioned below:

    • In July 2023, Sartorius AG completed the acquisition of the French company Polyplus, a leading provider of innovative technologies for cell and gene therapies.
    • In March 2020, Danaher Corporation completed the acquisition of the GE biopharma business.

    Market Segment Analysis

    Segmentations

    List of Sub-Segments

    Dominant and Fastest-Growing Segments

    Product-Type Analysis

    Media Bags and Containers, Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Fiber Cartridges, Mixing Systems, Tubing Assemblies, Sampling Systems, and Others.

    Media bags and containers are likely to be the dominant product category. Bioreactor is estimated to witness the fastest growth in the coming years.

    Method-Type Analysis

    Filtration, Cell Culture, Purification, Mixing, and Storage.

    Filtration is anticipated to remain the dominant segment whereas purification is estimated to witness the fastest growth in the years to come.

    Application-Type Analysis

    Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, and Others.

    Monoclonal antibody production is expected to remain the dominant segment whereas patient-specific cell therapies are estimated to be the fastest-growing segment

    End-User Type Analysis

    Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, and Contract Research Organizations & Manufacturers.

    Biopharmaceutical manufacturers are anticipated to remain the dominant category during the forecast period. Contract research organizations & manufacturers are likely to witness the fastest growth.

    Regional Analysis

    North America, Europe, China, Rest of Asia-Pacific, and The Rest of the World.

    In the years ahead, Europe is anticipated to be the dominant market, while China is expected to emerge as the fastest-growing market.

     

    Based on the product type, the market is segmented into media bags and containers, bioreactors, tangential-flow filtration devices, depth filters, disposable fiber cartridges, mixing systems, tubing assemblies, sampling systems, and others. Among these products, single-use media bags and containers dominate biopharmaceutical manufacturing, due to their flexibility, scalability, and cost-effectiveness, eliminating the need for cleaning and validation between batches while reducing the risk of cross-contamination.

    Based on the method type, the market is segmented into filtration, cell culture, purification, mixing, and storage. Among these methods, filtration is expected to remain the dominant segment of the market throughout the forecast period, as it is a fundamental and widely used step in biopharmaceutical processing for separating impurities and particulate matter from the desired product. It is a crucial method for achieving high product purity.

    Based on the application type, the market is segmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient-specific cell therapies, and others. Among these applications, monoclonal antibody production is expected to remain the dominant segment of the market in the coming years, as it plays a crucial role in treating various diseases, including cancer and autoimmune disorders, driving a high demand for their production.

    Based on the end-user type, the market is segmented into biopharmaceutical manufacturers, life science R&D companies & academic research, and contract research organizations & manufacturers. Among these end-users, biopharmaceutical manufacturers are expected to remain the biggest demand generator in the market during the forecast period. This is primarily owing to the increased flexibility, scalability, cost-efficiency, and reduced contamination risks offered by the single-use technologies, that completely align with the dynamic nature of biopharmaceutical production.

    In terms of regions, Europe is expected to remain the largest market for single-use systems during the forecast period, driven by stringent regulatory standards upheld by the European Medicines Agency (EMA), aligned with the adoption of single-use biopharma processing technologies for enhanced product quality and reduced cross-contamination risk.

    On the contrary, China is likely to witness the fastest growth in the market in the coming years, due to the significant growth in the biopharmaceutical industry in this region, driven by factors, such as rising healthcare expenditure and the active presence of the major companies, such as Danaher Corporation, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., in the region.

    Key Players

    The global market for single-use systems is very competitive and highly consolidated, with the leading companies capturing the lion’s market share. The major players compete on some of the governing factors including price, product offerings, regional presence, etc. The following are the key players in the single-use systems market.

    • Sartorius AG
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • Merck KGaA

    Research Methodology

    This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s single-use systems market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, etc.
    • COVID-19 impact and its recovery curve
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for existing and new players
    • Key success factors

    The single-use systems market is segmented into the following categories. 

    Single-Use Systems Market, by Product Type

    • Media Bags and Containers (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Bioreactors (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Tangential-Flow Filtration Devices (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Depth Filters (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Disposable Fiber Cartridges (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Mixing Systems (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Tubing Assemblies (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Sampling Systems (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)

    Single-Use Systems Market, by Method Type

    • Filtration (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Cell Culture (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Purification (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Mixing (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Storage (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)

    Single-Use Systems Market, by Application Type

    • Monoclonal Antibody Production (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Vaccine Production (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Plant Cell Cultivation (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Patient-Specific Cell Therapies (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)

    Single-Use Systems Market, by End-User Type

    • Biopharmaceutical Manufacturers (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Life Science R&D Companies & Academic Research (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)
    • Contract Research Organizations & Manufacturers (Regional Analysis: North America, Europe, China, Rest of Asia-Pacific, and RoW)

    Single-Use Systems Market, by Region

    • North America (Country Analysis: The USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, The UK, Spain, Italy, Turkey, and  Rest of Europe)
    • China
    • Rest of Asia-Pacific (Country Analysis: Japan, India, Australia, and Others)
    • Rest of the World (Country Analysis: Brazil, Argentina, South Africa, and Others)

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions

    The single-use systems market is estimated to grow at a healthy CAGR of 16.3% in the coming five years, driven by the increasing adoption of single-use technologies by biopharmaceutical manufacturers, the flexibility and cost-effectiveness offered by these solutions, and the growing demand for rapid and scalable manufacturing processes in the dynamic biopharmaceutical industry.

    Sartorius AG, Danaher Corporation, Thermo Fisher Scientific Inc., and Merck KGaA are the leading players in the single-use systems market. It is a highly consolidated market.

    Europe is expected to be dominant in the market in the coming years, driven by stringent regulatory standards upheld by the European Medicines Agency (EMA), aligned with the adoption of single-use bioprocess technologies for enhanced product quality and reduced cross-contamination risk. The presence of key industry players, such as Sartorius AG and Merck KGaA, further strengthens the regional market dominance.

    China is expected to be the fastest-growing market in the coming years, due to the significant growth in the biopharmaceutical industry in this region, driven by factors, such as rising healthcare expenditure and the active presence of major companies, such as Danaher Corporation, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., in the region.